Efficacy versus abundancy: which vaccination schemes can better prohibit deaths and active infections?

Omar El Deeb, Maya Jalloul
doi: https://doi.org/10.1101/2021.09.02.21263041

Article Information

doi 
https://doi.org/10.1101/2021.09.02.21263041
History 
  • September 5, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Omar El Deeb*,†,# and
  2. Maya Jalloul‡
  1. *Department of Natural Sciences, Lebanese American University
  2. †Faculty of Technology, Branch II, Lebanese University
  3. ‡Department of Economics, Lebanese American University
  1. ↵#Corresponding author; email: omar.eldeeb{at}lau.edu.lb
Back to top
Posted September 05, 2021.
Download PDF
Data/Code
Email
Efficacy versus abundancy: which vaccination schemes can better prohibit deaths and active infections?
Omar El Deeb, Maya Jalloul
medRxiv 2021.09.02.21263041; doi: https://doi.org/10.1101/2021.09.02.21263041
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area